Both CLSTN1 and ICAM5 were previously identified by HITS-CLIP as FMRP targets (Darnell et al., 2011), but subsequent analyses of their molecular mechanisms linked to FXS or FMRP are lacking. This evidence concerns the gene CLSTN1 and fragile X syndrome.